XBP EUROPE HOLDINGS INC (XBP)

US98400V1017 - Common Stock

1.06  0 (0%)

After market: 0.98 -0.08 (-7.55%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to XBP. XBP was compared to 99 industry peers in the Financial Services industry. XBP may be in some trouble as it scores bad on both profitability and health. XBP does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year XBP has reported negative net income.
In the past year XBP has reported a negative cash flow from operations.

1.2 Ratios

XBP has a Return On Assets of -14.85%. This is amonst the worse of the industry: XBP underperforms 91.92% of its industry peers.
Industry RankSector Rank
ROA -14.85%
ROE N/A
ROIC N/A
ROA(3y)-1.3%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

XBP has a Gross Margin (24.14%) which is in line with its industry peers.
XBP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

XBP does not have a ROIC to compare to the WACC, probably because it is not profitable.
XBP has more shares outstanding than it did 1 year ago.
The debt/assets ratio for XBP has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that XBP is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XBP (0.97) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACCN/A
WACC9.98%

2.3 Liquidity

XBP has a Current Ratio of 0.64. This is a bad value and indicates that XBP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.64, XBP is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
XBP has a Quick Ratio of 0.64. This is a bad value and indicates that XBP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.58, XBP is doing worse than 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.58

0

3. Growth

3.1 Past

XBP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.83%, which is quite impressive.
EPS 1Y (TTM)81.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

XBP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

63.64% of the companies in the same industry are cheaper than XBP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 75.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

XBP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

XBP EUROPE HOLDINGS INC

NASDAQ:XBP (12/20/2024, 8:00:02 PM)

After market: 0.98 -0.08 (-7.55%)

1.06

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners22.44%
Inst Owner Change0.84%
Ins Owners10.26%
Ins Owner Change0%
Market Cap31.98M
AnalystsN/A
Price TargetN/A
Short Float %1.81%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 75.15
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS5.07
BVpS-0.69
TBVpS-1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.14%
FCFM N/A
ROA(3y)-1.3%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 35.64
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.58
Altman-Z 0.97
F-Score5
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A